Replies to post #39828 on Curative Biotechnology Inc (CUBT)

[conix]

News on the clinical trials after this up list to NYSE is going to get the interest by bigger guys than us penny players.

And a corporate partner too.

If you are a legitimate, big cap biotech interested in CUBT and what they are doing, would you do a deal with an OTC company?

Or would I (the Big Cap biotech) wait until the company gets to a better exchange before you close on a partnership?